A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer

What's known on the subject? and What does the study add? Neoadjuvant chemotherapy is advocated for most patients with carcinoma invading bladder muscle. An improved risk‐stratification of clinical stage T2 (cT2) patients can potentially identify candidates who may derive maximal benefit from t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BJU international 2013-02, Vol.111 (2), p.240-248
Hauptverfasser:	Mitra, Anirban P., Skinner, Eila C., Miranda, Gus, Daneshmand, Siamak
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Agents - therapeutic use Biological and medical sciences Bladder cancer Carcinoma, Transitional Cell - drug therapy Carcinoma, Transitional Cell - mortality Carcinoma, Transitional Cell - pathology Carcinoma, Transitional Cell - surgery Chemotherapy, Adjuvant cT2 bladder cancer Cystectomy - methods Cystectomy - mortality Decision Support Systems, Clinical decision tree Decision Trees early cystectomy Epidemiologic Methods Female Humans Hydronephrosis - complications Hydronephrosis - mortality Hydronephrosis - pathology Male Medical sciences Middle Aged neoadjuvant chemotherapy Neoadjuvant Therapy Neoplasm Recurrence, Local - mortality Neoplasm Recurrence, Local - pathology Neoplasm Staging Nephrology. Urinary tract diseases pathological upstaging Tumors of the urinary system Urinary Bladder Neoplasms - drug therapy Urinary Bladder Neoplasms - mortality Urinary Bladder Neoplasms - pathology Urinary Bladder Neoplasms - surgery Urinary system involvement in other diseases. Miscellaneous Urinary tract. Prostate gland Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!